Antitumor and anticancer stem cell activities of eribulin mesylate and antiestrogens in breast cancer cells

Prospective identification of tumorigenic breast cancer cells

Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández et al. · Proceedings of the National Academy of Sciences · 2003 · 10.4K citations · Full text

Medicine, Cell Biology, Oncology +11

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

X. Li, Michael T. Lewis, Jian Huang et al. · JNCI Journal of the National Cancer Institute · 2008 · 1.8K citations · Full text

Medicine, Cancer Biology, Cell Biology +17

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Flora Iovino et al. · Cancer Research · 2009 · 1.2K citations · Full text

Medicine, Cell Biology, Oncology +17

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Javier Cortés, Joyce O’Shaughnessy, David Loesch et al. · The Lancet · 2011 · 1.1K citations

Medicine, Oncology, Pharmacotherapy +9

Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers

Tomonori Tanei, Koji Morimoto, Kenzo Shimazu et al. · Clinical Cancer Research · 2009 · 563 citations

Medicine, Oncology, Pharmacology +9